CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

ixmyelocel-t

Cell therapyexperimental

Clinical trial activity

7 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
7
Phase 3
1
Phase 4
0

Earliest trial started Apr 1, 2007 (NCT00468000)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2012

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • leukocytesTissue restoration

    leukocytes tissue restoration

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ixmyelocel-t
  • ixmyelocel-t

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01670981Phase 2Oct 1, 2012Vericel Corporation
NCT01616953Phase 1/Phase 2 (Phase 2)Aug 1, 2012University of Michigan
NCT01483898Phase 3Feb 1, 2012Vericel Corporation
NCT01020968Phase 2Dec 1, 2009Minneapolis Heart Institute, Vericel Corporation
NCT00765518Phase 2Sep 1, 2008University of Utah, Vericel Corporation
NCT00505219Phase 2Sep 1, 2007Johns Hopkins University, Vericel Corporation
NCT00468000Phase 2Apr 1, 2007Jobst Vascular Center, Vericel Corporation
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Vericel CorporationFor profit6622007
Jobst Vascular CenterAcademic/Hospital1012007
Johns Hopkins UniversityAcademic/Hospital1012007
Minneapolis Heart InstituteAcademic/Hospital1012009
University of MichiganAcademic/Hospital1112012
University of UtahAcademic/Hospital1012008
6 organizations
Page 1 / 1